# Freeport-Mcmoran Inc: overview

FCX · NYSE · CIK 831259 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fcx.md) · [Financials](/companies/fcx/financials.md) · [Filings](/companies/fcx/filings.md) · [Insiders](/companies/fcx/insiders.md)

Latest reported revenue: [$6.92bn](/filings/0000831259-26-000036.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000831259-26-000036).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6,680](/filings/0000831259-25-000050.md) | [5,880 d](/filings/0000831259-26-000012.md) | [5,574](/filings/0000831259-26-000025.md) | [7,526](/filings/0000831259-26-000036.md) | [6,819](/filings/0000831259-25-000050.md) | [5,267 d](/filings/0000831259-26-000012.md) | [6,254](/filings/0000831259-26-000025.md) | [6,917](/filings/0000831259-26-000036.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [29.0%](/filings/0000831259-25-000050.md) | [21.1% d](/filings/0000831259-26-000012.md) | [23.4%](/filings/0000831259-26-000025.md) | [32.3%](/filings/0000831259-26-000036.md) | [28.9%](/filings/0000831259-25-000050.md) | [15.4% d](/filings/0000831259-26-000012.md) | [34.2%](/filings/0000831259-26-000025.md) | [29.0%](/filings/0000831259-26-000036.md) |
| Net margin | % | [18.5%](/filings/0000831259-25-000050.md) | [12.3% d](/filings/0000831259-26-000012.md) | [14.2%](/filings/0000831259-26-000025.md) | [10.3%](/filings/0000831259-26-000036.md) | [18.3%](/filings/0000831259-25-000050.md) | [10.7% d](/filings/0000831259-26-000012.md) | [22.2%](/filings/0000831259-26-000025.md) | [14.2%](/filings/0000831259-26-000036.md) |
| Diluted EPS | $ per share | [0.36](/filings/0000831259-25-000050.md) | not reported | [0.24](/filings/0000831259-26-000025.md) | [0.53](/filings/0000831259-26-000036.md) | [0.46](/filings/0000831259-25-000050.md) | not reported | [0.61](/filings/0000831259-26-000025.md) | [0.68](/filings/0000831259-26-000036.md) |
| Free cash flow | $m | [673 d](/filings/0000831259-25-000050.md) | [197 d](/filings/0000831259-26-000012.md) | [(114)](/filings/0000831259-26-000025.md) | [934 d](/filings/0000831259-26-000036.md) | [608 d](/filings/0000831259-25-000050.md) | [(312) d](/filings/0000831259-26-000012.md) | [522](/filings/0000831259-26-000025.md) | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [22.4](/filings/0000831259-24-000011.md) | [23.3](/filings/0000831259-25-000006.md) | [22.7](/filings/0000831259-26-000012.md) | [25.2](/filings/0000831259-26-000012.md) | [25.2](/filings/0000831259-26-000012.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [37.3%](/filings/0000831259-24-000011.md) | [30.2%](/filings/0000831259-25-000006.md) | [27.4%](/filings/0000831259-26-000012.md) | [27.3%](/filings/0000831259-26-000012.md) | [25.9%](/filings/0000831259-26-000012.md) |
| Net margin | % | [23.9%](/filings/0000831259-24-000011.md) | [19.2%](/filings/0000831259-25-000006.md) | [16.5%](/filings/0000831259-26-000012.md) | [17.5%](/filings/0000831259-26-000012.md) | [16.5%](/filings/0000831259-26-000012.md) |
| Diluted EPS | $ per share | [2.90](/filings/0000831259-22-000009.md) | not reported | not reported | not reported | not reported |
| Free cash flow | $bn | [5.6](/filings/0000831259-24-000011.md) | [1.7](/filings/0000831259-25-000006.md) | [0.5](/filings/0000831259-26-000012.md) | [2.4](/filings/0000831259-26-000012.md) | [1.1](/filings/0000831259-26-000012.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fcx/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $7.67bn | 121,954,704 |  | Reduced −3,916,324 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $5.91bn | 93,905,396 |  | Added +502,203 |
| [Fisher Asset Management, LLC](/funds/850529.md) | 2026-06-30 | $4.21bn | 66,922,014 |  | Added +1,832,408 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $4.18bn | 66,485,424 |  | Added +2,300,416 |
| [Capital Research Global Investors](/funds/1422848.md) | 2026-06-30 | $2.61bn | 41,503,051 |  | Added +661,121 |
| [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $2.35bn | 37,381,125 |  | Added +2,062,348 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $2.29bn | 36,401,174 |  | Reduced −5,944,328 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $2.04bn | 32,558,233 |  | Added +275,698 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $1.91bn | 30,998,642 |  | Added +10,056,398 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $1.63bn | 25,994,123 |  | Reduced −233,529 |

## Recent filings

[All 1,470 filings](/companies/fcx/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 08:08 ET | [8-K](/filings/0000831259-26-000045.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000831259-26-000045 |
| 2026-10-02 | 08:35 ET | [8-K](/filings/0000831259-26-000043.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000831259-26-000043 |
| 2026-09-08 | 17:18 ET | [8-K](/filings/0000831259-26-000038.md) | 8.01 Other events | 0000831259-26-000038 |
| 2026-08-06 | 17:17 ET | [10-Q](/filings/0000831259-26-000036.md) | Quarterly report, period 2026-06-30 | 0000831259-26-000036 |
| 2026-07-23 | 08:06 ET | [8-K](/filings/0000831259-26-000033.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000831259-26-000033 |
| 2026-06-10 | 16:31 ET | [8-K](/filings/0000831259-26-000030.md) | 5.07 Shareholder vote results | 0000831259-26-000030 |
| 2026-05-20 | 16:17 ET | [8-K](/filings/0000831259-26-000027.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000831259-26-000027 |
| 2026-05-08 | 17:11 ET | [10-Q](/filings/0000831259-26-000025.md) | Quarterly report, period 2026-03-31 | 0000831259-26-000025 |
| 2026-04-23 | 16:05 ET | [DEF 14A](/filings/0001193125-26-173666.md) | Proxy statement, period 2026-06-10 | 0001193125-26-173666 |
| 2026-04-23 | 08:09 ET | [8-K](/filings/0000831259-26-000021.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000831259-26-000021 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000831259-26-000012.md), filed Feb 13, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 831259
- Tickers: FCX
- Exchange: NYSE
- SIC code: 1000 Metal Mining
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 08:10 ET. No prices; not investment advice.